Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 2 analysts offering 12 month price targets for Shanghai Henlius Biotech Inc have a median target of 22.51, with a high estimate of 24.65 and a low estimate of 20.37. The median estimate represents a -2.35% decrease from the last price of 23.05.
High | 6.9% | 24.65 |
Med | -2.3% | 22.51 |
Low | -11.6% | 20.37 |
Earnings history & estimates in CNY
Average growth rate | +8.63% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +222.86% |
More ▼